Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT01702194
PHASE1
TD-1211 IV/Oral Mass Balance Study
Sponsor: Glycyx Therapeutics
View on ClinicalTrials.gov
Summary
The purpose of this study is to determine TD-1211 is processed by the body.
Official title: A Single-Dose, Fixed-Sequence, Two-Period, Two-Treatment Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of TD-1211 Following an Intravenous Infusion and an Oral Dose of [14C]TD-1211 in Healthy Male Subjects
Key Details
Gender
MALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2012-11
Completion Date
2013-03
Last Updated
2026-05-22
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
TD-1211 IV [C14]
DRUG
TD-1211 PO [C14]
Locations (1)
Covance
Madison, Wisconsin, United States